Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · IEX Real-Time Price · USD
0.628
-0.083 (-11.68%)
At close: Apr 26, 2024, 4:00 PM
0.650
+0.022 (3.47%)
After-hours: Apr 26, 2024, 6:14 PM EDT
Eyenovia Market Cap
Eyenovia has a market cap or net worth of $31.79 million as of April 26, 2024. Its market cap has decreased by -81.36% in one year.
Market Cap
31.79M
Enterprise Value
35.65M
1-Year Change
-81.36%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since January 25, 2018, Eyenovia's market cap has decreased from $98.60M to $31.79M, a decrease of -67.76%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 33.70M | 21.66% |
| Apr 24, 2024 | 27.70M | 7.78% |
| Apr 23, 2024 | 25.70M | 4.90% |
| Apr 22, 2024 | 24.50M | -9.59% |
| Apr 19, 2024 | 27.10M | 7.54% |
| Apr 18, 2024 | 25.20M | -1.18% |
| Apr 17, 2024 | 25.50M | -2.67% |
| Apr 16, 2024 | 26.20M | 0.38% |
| Apr 15, 2024 | 26.10M | 3.98% |
| Apr 12, 2024 | 25.10M | -10.68% |
| Apr 11, 2024 | 28.10M | 9.34% |
| Apr 10, 2024 | 25.70M | -11.68% |
| Apr 9, 2024 | 29.10M | -15.90% |
| Apr 8, 2024 | 34.60M | -18.01% |
| Apr 5, 2024 | 42.20M | -0.24% |
| Apr 4, 2024 | 42.30M | -0.70% |
| Apr 3, 2024 | 42.60M | -6.78% |
| Apr 2, 2024 | 45.70M | -1.93% |
| Apr 1, 2024 | 46.60M | -0.21% |
| Mar 28, 2024 | 46.70M | - |
| Mar 27, 2024 | 46.70M | -2.51% |
| Mar 26, 2024 | 47.90M | -14.31% |
| Mar 25, 2024 | 55.90M | 3.52% |
| Mar 22, 2024 | 54.00M | -3.40% |
| Mar 21, 2024 | 55.90M | -3.29% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunoPrecise Antibodies | 32.10M |
| MiNK Therapeutics | 30.85M |
| Singular Genomics Systems | 30.18M |
| Nutriband | 30.16M |
| NeuroOne Medical Technologies | 30.08M |
| Femasys | 29.39M |
| Acurx Pharmaceuticals | 29.37M |
| IGC Pharma | 29.21M |